Prediction Case File
YouTubePartially Resolved

Epic Print Coming: Risk-On RALLY? HIMS +13% MSTR+13% HYPE +20% MRNA +180%. Yields Down = 2021 Vibes!

2 extracted signals · 1 resolved · 1 still active

Beat The Denominator profile imageBeat The DenominatorIndependent analyst profile
Source published
19 Aug 2026, 21:20 UTC
Recorded by Tahlil Plus
20 Aug 2026, 00:13 UTC
Video preview for Epic Print Coming: Risk-On RALLY? HIMS +13% MSTR+13% HYPE +20% MRNA +180%. Yields Down = 2021 Vibes!
Source overview

AI-generated source summary

The market analysis focuses on the recent

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Partially Resolved
Signals
2
Extracted from this source
Open
1
Still being tracked
Successful
1
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
100%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    2 eligible signals linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  7. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

Beat The Denominator

Platform-wide history, separate from this source evaluation.

Reliability
52.4
Tracked signals
25
Historical success
50.0%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail